Venous Thromboembolism

Venous thromboembolism (VTE), is a condition in which unwanted blood clots form in the body. These blood clots can sometimes lead to serious health conditions or even death. Patients admitted to the hospital are at increased risk for this condition, especially if they have surgery or stay in the hospital for a long time.

Risk Factors

VTE risk factors, presentation and morbidity may differ among races, ages, and gender. Some risk factors are unique to race (e.g. sickle cell trait in African Americans) while some to gender (e.g. pregnancy and postpartum)

 

VTE remains a serious and frequently fatal condition. It is the most common preventable cause of hospital death.

According to the U.S. Centers for Disease Control and Prevention (CDC), nationwide approximately 100,000 patients with VTE die each year. Between 30–50 percent of patients who develop lower extremity deep vein thrombosis endure long-term swelling, pain, discoloration, and even ulcers in the affected limb. In addition, between 10–30 percent of patients who survive a first VTE occurrence will likely develop another VTE within five years.

The CDC reports that the costs associated with health care-associated VTE exceed $5 billion each year, and as many as 70 percent of these cases are preventable. The costs savings of reducing VTEs is significant.

The Hospital and Healthsystem Association of Pennsylvania’s VTE project provides tools and support, and facilitates collaboration to help facilities prevent VTEs.


HAP Contacts

For more information, contact Janette Bisbee. Media inquiries should be directed to Liam Migdail, director, media relations.

HAP News

October 21, 2021

October is Patient-Centered Care Awareness Month

October is Patient-Centered Care Awareness Month, a time to raise awareness about the importance of providing care that is respectful of, and responsive to individual patient preferences, needs, and values.

+